Dr. Hazen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
# Jb1
Cleveland, OH 44195Phone+1 800-223-2273
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1994 - 1996
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1992 - 1994
- Washington University in St. Louis School of MedicineClass of 1992
Certifications & Licensure
- OH State Medical License 1997 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Elected Member The American Society for Clinical Investigation, 2003
- Fellow (FACC) American College of Cardiology
Clinical Trials
- GeneBank at the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease Start of enrollment: 2001 Jan 01
- Gut Flora Metabolite Reduction After Dietary Intervention (GRADY) Start of enrollment: 2014 Apr 04
Publications & Presentations
PubMed
- 1530 citationsA comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery diseaseMajid Nikpay, Anuj Goel, Won H-H., Leanne M. Hall, Christina Willenborg
Nature Genetics. 2015-09-07 - 102 citationsIncreased carotid intima media thickness and cardiac biomarkers in HIV infected children.Grace A. McComsey, MaryAnn O'Riordan, Stanley L. Hazen, Dalia El-Bejjani, Shweta Bhatt
AIDS. 2007-05-11 - 2041 citationsIntestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosisRobert A. Koeth, Zeneng Wang, Bruce S. Levison, Jennifer A. Buffa, Elin Org
Nature Medicine. 2013-05-01
Journal Articles
- Dietary Metabolism, the Gut Microbiome, and Heart FailureStanley L Hazen, Daniel Y Li, Nature
- Development of a Gut Microbe–Targeted Nonlethal Therapeutic to Inhibit Thrombosis PotentialStanley Hazen, MD, Nature
- Elevated Levels of Plasma Symmetric Dimethylarginine and Increased Arginase Activity as Potential Indicators of Cardiovascular Comorbidity in Rheumatoid ArthritisStanley Hazen, MD, BioMed Central
- Join now to see all
Press Mentions
- New Research Suggests Contracting This Disease Will Double Your Risk of a Heart AttackOctober 31st, 2024
- Having This Infection Doubles Your Heart Attack Risk, New Research FindsOctober 28th, 2024
- History of COVID-19 Doubles Long-Term Risk of Heart Attack, Stroke and Death, Reveals StudyOctober 16th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: